Isothermal nucleic acid amplification system for simultaneously detecting brucella and mycobacterium bovis in single tube and use thereof

The rapid and accurate detection of Brucella and Mycobacterium bovis using an isothermal nucleic acid amplification system overcomes the limitations of traditional PCR technology in field applications and provides a high-sensitivity and specific solution for dual-channel detection in a single tube.

WO2026237147A1PCT designated stage Publication Date: 2026-11-19JIANGSU QITIAN GENE BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2025/106772
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-15
Filing Date
2025-07-03
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing technologies are insufficient for the rapid and accurate simultaneous detection of Brucella and Mycobacterium bovis in field settings, and traditional PCR technology requires complex thermal cyclers, which limits its application in point-of-care testing (POCT).

Method used

An isothermal nucleic acid amplification system is used, which includes primers and probes for Brucella and Mycobacterium bovis, dNTPs, polyethylene glycol, dithiothreitol, creatine phosphate, creatine kinase, ATP, Tris, potassium acetate, DNA polymerase, UvsX protein, and UvsY protein, enabling dual-channel detection in a single tube, eliminating heating and cooling steps, and improving detection efficiency.

Benefits of technology

It achieves high sensitivity and specificity for the simultaneous detection of Brucella and Mycobacterium bovis in a single tube, reduces equipment requirements, is suitable for mobile on-site testing, and is adaptable to resource-scarce environments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2025106772_19112026_PF_FP_ABST
    Figure CN2025106772_19112026_PF_FP_ABST
Patent Text Reader

Abstract

Provided are an isothermal nucleic acid amplification system for simultaneously detecting Brucella and Mycobacterium bovis in a single tube and a use thereof. The isothermal nucleic acid amplification system comprises a Brucella primer probe, a Mycobacterium bovis primer probe, dNTP, polyethylene glycol, dithiothreitol, phosphocreatine, creatine kinase, ATP, Tris, potassium acetate, DNA polymerase, the UvsX protein, and the UvsY protein. The provided isothermal nucleic acid amplification system can achieve simultaneous detection of the two pathogens in milk in a single tube. Dual-channel detection involves no competitive reactions and has high specificity and high sensitivity.
Need to check novelty before this filing date? Find Prior Art

Description

An isothermal nucleic acid amplification system for simultaneous detection of Brucella and Mycobacterium bovis in one tube and its application. Technical Field

[0001] This application belongs to the field of in vitro diagnostic technology, and in particular relates to an isothermal nucleic acid amplification system for the simultaneous detection of Brucella and Mycobacterium bovis in one tube and its application. Background Technology

[0002] Brucella is a Gram-negative bacterium, comprising six species: Brucella bovis (Brucella abortus), Brucella melitensis (Brucella malata), Brucella suis, Brucella canis, Brucella rodentii, and Brucella ovis. Brucellosis primarily occurs in the Middle East, Africa, Latin America, Central Asia, and the Mediterranean region, with approximately 500,000 cases worldwide. After invading the body, the bacteria travel through the lymphatic system to the lymph nodes, where they are phagocytosed by phagocytes. If not killed by phagocytes, the bacteria multiply intracellularly, causing the phagocytes to rupture. This release of bacteria into the lymphatic system and bloodstream leads to bacteremia. In the bloodstream, the bacteria are further engulfed by phagocytes and carried throughout the body, multiplying in the mononuclear phagocyte system of the liver, spleen, lymph nodes, and bone marrow, forming multiple lesions. Clinically, this results in not only bacteremia and sepsis but also toxemia.

[0003] Bovine tuberculosis is a zoonotic infectious disease, and cross-transmission between humans and animals is one of the important reasons for its widespread prevalence. Members of the genus *Mycobacterium* are all aerobic bacteria, with straight or curved, slender morphologies, and are Gram-positive bacilli. Under certain conditions, they can produce hyphae, but these hyphae become rod-shaped or spherical after agitation. *Mycobacterium bovis* primarily infects more than 50 species of warm-blooded animals, including ungulates, marsupials, carnivores, primates, pinnipeds, and rodents, as well as more than 20 species of birds such as parrots, stone pigeons, and North American crows. Cattle are the most susceptible animals, especially dairy cows, followed by buffalo and cattle, often causing systemic tuberculosis in various livestock. The production of milk, beef, and related products makes the relationship between humans and cattle closer than the relationship between humans and other animals, making the transmission of bovine tuberculosis more difficult to control. Research on the pathogen of bovine tuberculosis is a prerequisite for the effective control and elimination of bovine tuberculosis. Differentiation and identification of pathogens is a crucial part of pathogen research, so it is necessary to clarify the relationships between them and be able to identify them quickly and accurately.

[0004] Currently, traditional detection techniques for Brucella and Mycobacterium bovis mainly include pathogen isolation techniques, culture characteristic identification techniques, serological detection techniques, immunological detection techniques, and molecular biology techniques (in vitro nucleic acid amplification diagnosis).

[0005] Pathogen detection involves isolating and culturing bacilli from infected blood or tissue using solid culture media such as serum glucose agar or tryptone-soy agar. The detection principle relies on identifying bacilli based on their cell morphology, staining characteristics, colony morphology, growth characteristics, biochemical reactions, and Brucella polyclonal antibody agglutination assays. This method is relatively inexpensive and offers both qualitative and quantitative analysis. However, it also suffers from low isolation rates, susceptibility to contamination, and time-consuming processes. Furthermore, Brucella isolation poses biosafety risks to the environment and personnel, thus limiting its application.

[0006] The serum agglutination reaction (SAT) is a classic serological agglutination reaction. It refers to the aggregation of particulate antigens, such as erythrocytes and bacteria, with their corresponding antibodies in the presence of appropriate electrolytes over a certain period of time, forming visible agglutinations. SAT is a legally mandated test for brucellosis detection in my country. Its advantages include high sensitivity in detecting serum immunoglobulin M (IgM), ease of operation, and quick interpretation, making it a valuable diagnostic tool. However, its specificity is poor when used alone, and it cannot differentiate between artificial immunization and natural infection. Furthermore, antibody titers in some infected animals may not reach diagnostic levels, leading to potential misdiagnosis and missed diagnosis.

[0007] In vitro nucleic acid amplification diagnostics, the artificial replication of genetic material, has permeated all fields of life sciences and biotechnology, such as pathogen detection, genetic engineering, synthetic biology, genotyping, food testing, and medical diagnostics. In vitro diagnostics originated from polymerase chain reaction (PCR) technology, which, by providing continuous temperatures conducive to nucleic acid chain denaturation, primer annealing, and enzymatic extension, replicates a single nucleic acid molecule to billions of copies in vitro. This increased molecule count makes nucleic acid processing and subsequent applications easier and has generated tremendous creativity in applications. However, it requires complex thermal cyclers to provide cyclic heating and cooling processes, which significantly limits the use of PCR technology in field settings outside the laboratory, hindering its application in point-of-care testing (POCT).

[0008] In summary, providing a novel in vitro nucleic acid amplification method for the simultaneous detection of Brucella and Mycobacterium bovis has become one of the urgent problems to be solved in this field. Summary of the Invention

[0009] This application provides an isothermal nucleic acid amplification system for the simultaneous detection of Brucella and Mycobacterium bovis in one tube and its application. The system achieves the simultaneous detection of two pathogens through isothermal nucleic acid amplification, with dual-channel detection without competitive reactions, high specificity, and high sensitivity.

[0010] In a first aspect, this application provides an isothermal nucleic acid amplification system for the simultaneous detection of Brucella and Mycobacterium bovis in one tube, the isothermal nucleic acid amplification system comprising Brucella primer probe, Mycobacterium bovis primer probe, dNTP, polyethylene glycol, dithiothreitol, creatine phosphate, creatine kinase, ATP, Tris, potassium acetate, DNA polymerase, UvsX protein and UvsY protein.

[0011] This application provides an isothermal nucleic acid amplification system. Isothermal nucleic acid amplification solves the problem of PCR amplification relying on thermal cycling, reduces equipment requirements, and opens up a new avenue for amplification that transcends laboratory limitations and can be performed in resource-scarce environments. By reducing amplification time and eliminating repetitive heating and cooling steps, it improves detection efficiency. The faster reaction occurs not only due to the reduction in heating and cooling time but also because multiple molecular reactions can proceed asynchronously, rather than being forced to operate sequentially in artificial heating and cooling cycles.

[0012] In the isothermal nucleic acid amplification system provided in this application, dNTPs are the raw materials for DNA synthesis; polyethylene glycol enhances the catalytic activity of the enzyme, simulating real biomolecular conditions in vivo; dithiothreitol is used to remove free sulfhydryl groups and stabilize the enzyme system; creatine phosphate, creatine kinase, and ATP provide reaction energy; Tris and potassium acetate are used to stabilize and dissolve DNA in solution; DNA polymerase synthesizes new DNA templates homologous to the target nucleic acid by extending nucleotide building blocks from bound primers; UvsX protein is a recombinase used for gene recombination, DNA repair, and replication; UvsY protein is a recombinase loader factor and recombinant mediator protein that can stimulate single-stranded DNA dependence of UvsX, ATPase activity, and reduce the critical concentration of UvsX required for activity.

[0013] Preferably, the isothermal nucleic acid amplification system includes Brucella primers and probes, Mycobacterium bovis primers and probes, 1–2 mmol / L dNTP, 5%–10% w / v polyethylene glycol, 2–10 mmol / L dithiothreitol, 25–50 mmol / L creatine phosphate, 2.7–4.3 μg / U creatine kinase, 5–10 mmol / L ATP, 30–100 nM Tris, 25–75 mmol / L potassium acetate, 10–100 ng / μL DNA polymerase, 10–100 ng / μL UvsX protein, and 10–100 ng / μL UvsY protein.

[0014] The specific values ​​in the range of 1 to 2 mmol / L can be 1 mmol / L, 1.2 mmol / L, 1.4 mmol / L, 1.5 mmol / L, 1.6 mmol / L, 1.8 mmol / L, or 2 mmol / L, etc.

[0015] The specific point values ​​in the above 5% to 10% range can be 5%, 6%, 7%, 7.5%, 8%, 9%, or 10%, etc.

[0016] The specific values ​​in the range of 2 to 10 mmol / L can be 2 mmol / L, 3 mmol / L, 4 mmol / L, 5 mmol / L, 6 mmol / L, 7 mmol / L, 8 mmol / L, 9 mmol / L, or 10 mmol / L, etc.

[0017] The specific values ​​in the range of 25–50 mmol / L can be 25 mmol / L, 30 mmol / L, 35 mmol / L, 40 mmol / L, 45 mmol / L, or 50 mmol / L, etc.

[0018] The specific point values ​​in the range of 2.7 to 4.3 μg / U can be 2.7 μg / U, 3 μg / U, 3.3 μg / U, 3.5 μg / U, 3.7 μg / U, 4 μg / U, or 4.3 μg / U, etc.

[0019] The specific values ​​in the range of 5 to 10 mmol / L can be 5 mmol / L, 6 mmol / L, 7 mmol / L, 7.5 mmol / L, 8 mmol / L, 9 mmol / L, or 10 mmol / L, etc.

[0020] The specific point values ​​in the range of 30 to 100 nM can be 30 nM, 40 nM, 50 nM, 60 nM, 70 nM, 80 nM, 90 nM, or 100 nM, etc.

[0021] The specific values ​​in the range of 25–75 mmol / L can be 25 mmol / L, 30 mmol / L, 35 mmol / L, 40 mmol / L, 45 mmol / L, 50 mmol / L, 55 mmol / L, 60 mmol / L, 65 mmol / L, 70 mmol / L, or 75 mmol / L, etc.

[0022] The specific values ​​in the range of 10–100 ng / μL can be 10 ng / μL, 20 ng / μL, 30 ng / μL, 40 ng / μL, 50 ng / μL, 60 ng / μL, 70 ng / μL, 80 ng / μL, 90 ng / μL, or 100 ng / μL, etc.

[0023] Preferably, the DNA polymerase is derived from Bacillus subtilis and / or Staphylococcus aureus.

[0024] Preferably, the polyethylene glycol includes polyethylene glycol 35K.

[0025] Preferably, the isothermal nucleic acid amplification system is a weakly alkaline system.

[0026] Preferably, the Brucella primer probe includes a first primer, a second primer, and a first probe.

[0027] Preferably, the isothermal nucleic acid amplification system includes a first primer of 200–420 nmol / L, a second primer of 200–420 nmol / L, and a first probe of 100–150 nmol / L.

[0028] The specific values ​​of 200–420 nmol / L mentioned above can be 200 nmol / L, 225 nmol / L, 250 nmol / L, 275 nmol / L, 300 nmol / L, 325 nmol / L, 350 nmol / L, 375 nmol / L, 400 nmol / L, or 420 nmol / L, etc.

[0029] The specific values ​​of 100-150 nmol / L mentioned above can be 100 nmol / L, 110 nmol / L, 120 nmol / L, 125 nmol / L, 130 nmol / L, 140 nmol / L, or 150 nmol / L, etc.

[0030] Preferably, the nucleic acid sequence of the first primer includes the sequence shown in SEQ ID NO.1.

[0031] Preferably, the nucleic acid sequence of the second primer includes the sequence shown in SEQ ID NO.2.

[0032] Preferably, the nucleic acid sequence of the first probe includes the sequences shown in SEQ ID NO.3 and SEQ ID NO.4.

[0033] SEQ ID NO. 1: TCAATGCCATCATGTCGCGCGCTCTGCAGTC.

[0034] SEQ ID NO. 2: TCCTTACGCCCAACGATATCGATCGATTCCG.

[0035] SEQ ID NO. 3: CTTAATGATGGCAAGCGCAAGGTGCATGA.

[0036] SEQ ID NO. 4: GCGCGTTCTGCCGAC.

[0037] Preferably, the nucleic acid sequence of the first probe is as follows:

[0038] CTTAATGATGGCAAGCGCAAGGTGCATGA(SEQ ID NO.3) / iHEXdT / / idSp / / iBHQ1dT / GCGC GTTCTGCCGAC(SEQ ID NO.4);

[0039] Wherein, iHEXdT is a fluorescent reporter group, idSp is a fluorescent reporter group and a quencher group with a spacing of at least 2-5 T bases, where T is replaced by a tetrahydrofuran residue, and iBHQ1dT is a fluorescent quencher group.

[0040] Preferably, the bovine tuberculosis mycobacterium primer probe includes a third primer, a fourth primer, and a second probe.

[0041] Preferably, the isothermal nucleic acid amplification system includes a 200–420 nmol / L third primer, a 200–420 nmol / L fourth primer, and a 100–150 nmol / L second probe.

[0042] The specific values ​​of 200–420 nmol / L mentioned above can be 200 nmol / L, 225 nmol / L, 250 nmol / L, 275 nmol / L, 300 nmol / L, 325 nmol / L, 350 nmol / L, 375 nmol / L, 400 nmol / L, or 420 nmol / L, etc.

[0043] The specific values ​​of 100-150 nmol / L mentioned above can be 100 nmol / L, 110 nmol / L, 120 nmol / L, 125 nmol / L, 130 nmol / L, 140 nmol / L, or 150 nmol / L, etc.

[0044] Preferably, the nucleic acid sequence of the third primer includes the sequence shown in SEQ ID NO.5.

[0045] Preferably, the nucleic acid sequence of the fourth primer includes the sequence shown in SEQ ID NO.6.

[0046] Preferably, the nucleic acid sequence of the second probe includes the sequences shown in SEQ ID NO.7 and SEQ ID NO.8.

[0047] SEQ ID NO. 5: CACTAGTGCGCGGACATCGCGTGATCGTT.

[0048] SEQ ID NO. 6: CAGCCAGATGCTGCTCCGTGTCGATTAGATGAGAA.

[0049] SEQ ID NO. 7: CGATAAGATCAGAACAGGTCATTGCGTCATT.

[0050] SEQ ID NO.8: TCGATTGACTATAGCT.

[0051] Preferably, the nucleic acid sequence of the second probe is as follows:

[0052] CGATAAGATCAGAACAGGTCATTGCGTCATT(SEQ ID NO.7) / i6FAMdT / / idSp / C / iBHQ1dT / TCGATTGACTATAGCT(SEQ ID NO.8)-Spacer;

[0053] In this context, i6FAMdT is the fluorescent reporter group, idSp is the fluorescent reporter group and the quencher group separated by at least 2-5 bases T, where T is replaced by tetrahydrofuran residues, and iBHQ1dT is the fluorescent quencher group.

[0054] Secondly, this application provides an isothermal nucleic acid amplification kit for simultaneously detecting Brucella and Mycobacterium bovis in one tube, the isothermal nucleic acid amplification kit comprising the isothermal nucleic acid amplification system described in the first aspect.

[0055] Thirdly, this application provides the use of the isothermal nucleic acid amplification system as described in the first aspect and / or the isothermal nucleic acid amplification kit as described in the second aspect in the isothermal amplification of Brucella and / or Mycobacterium bovis.

[0056] Fourthly, this application provides an isothermal nucleic acid amplification method for simultaneously detecting Brucella and Mycobacterium bovis in one tube. The isothermal nucleic acid amplification method includes: mixing a nucleic acid sample with the isothermal nucleic acid amplification system described in the first aspect to obtain a mixed solution, performing an isothermal amplification reaction, detecting the fluorescence signal in the amplification system, and obtaining the detection result.

[0057] Based on isothermal nucleic acid amplification, this application proposes an accessible sample loading concept, which eliminates the traditional manual micro-pipette loading method and uses a large sample loading volume of 25-50 μL for amplification reaction. This solves the problem of precise micro-pipette loading in mobile on-site nucleic acid testing, allowing the general public to operate the test manually by following the steps, while further improving the detection sensitivity.

[0058] The isothermal nucleic acid amplification method provided in this application can be applied to fields such as animal disease control, inspection and quarantine, and customs control, for example, to detect the presence of Brucella and Mycobacterium bovis in milk samples.

[0059] Preferably, the volume of the nucleic acid sample is 3 to 30 μL (e.g., it can be 3 μL, 5 μL, 7 μL, 10 μL, 15 μL, 20 μL, 23 μL, 25 μL, 27 μL or 30 μL, etc.).

[0060] Preferably, the volume of the mixture is 45–55 μL (e.g., 45 μL, 47 μL, 49 μL, 50 μL, 51 μL, 53 μL, or 55 μL).

[0061] Preferably, the mixture contains magnesium acetate.

[0062] Preferably, the concentration of magnesium acetate in the mixture is 100-200 mmol (e.g., 100 mmol, 120 mmol, 140 mmol, 150 mmol, 160 mmol, 180 mmol or 200 mmol, etc.).

[0063] Preferably, the volume of magnesium acetate in the mixture is 3 to 7 μL (e.g., 3 μL, 4 μL, 4.5 μL, 5 μL, 5.5 μL, 6 μL, or 7 μL, etc.).

[0064] Preferably, the mixture contains 3–10 μL (e.g., 3 μL, 4 μL, 4.5 μL, 5 μL, 5.5 μL, 6 μL, 7 μL, 8 μL, 9 μL, or 10 μL, etc.) of nucleic acid sample, 3–7 μL (e.g., 3 μL, 4 μL, 4.5 μL, 5 μL, 5.5 μL, 6 μL, or 7 μL, etc.) of magnesium acetate at a concentration of 100–200 mmol, and the isothermal nucleic acid amplification system described in the first aspect. The volume of the mixture is 45–55 μL (e.g., 45 μL, 47 μL, 49 μL, 50 μL, 51 μL, 53 μL, or 55 μL, etc.).

[0065] Preferably, the mixture contains 10–30 μL (e.g., 10 μL, 15 μL, 20 μL, 22 μL, 24 μL, 25 μL, 26 μL, 28 μL, or 30 μL, etc.) of nucleic acid sample and the isothermal nucleic acid amplification system described in the first aspect, and the volume of the mixture is 45–55 μL (e.g., 45 μL, 47 μL, 49 μL, 50 μL, 51 μL, 53 μL, or 55 μL, etc.).

[0066] Preferably, the temperature of the isothermal amplification reaction is 35-45°C (e.g., 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 44°C, or 45°C, etc.).

[0067] Preferably, the isothermal amplification reaction time is 5 to 40 minutes (e.g., 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 27 minutes, 29 minutes, 30 minutes, 31 minutes, 33 minutes, 35 minutes, or 40 minutes, etc.).

[0068] Preferably, the isothermal amplification reaction further includes a step of mixing and centrifuging the mixture, and pre-reacting for 3 to 5 minutes (e.g., 3 minutes, 3.5 minutes, 4 minutes, 4.5 minutes, or 5 minutes).

[0069] Other specific point values ​​within the range of the above values ​​can be selected, and will not be elaborated on here.

[0070] Compared with the prior art, this application has the following beneficial effects:

[0071] (1) The isothermal nucleic acid amplification system provided in this application can simultaneously detect two pathogens in milk in one tube. The dual-channel detection has no competitive reaction, high specificity, and sensitivity up to 1 CFU / mL.

[0072] (2) The detection method provided in this application, based on the specific isothermal nucleic acid amplification system provided in this application, can achieve large sample volume amplification, which solves the problem of precise micro-sample addition in mobile on-site nucleic acid testing. The equipment used in the detection method is small and portable, which can realize mobile testing, bedside testing, battlefield medical and other scenarios. No large equipment is required, and the results are automatically interpreted. The detection pipeline can be set up at will in individual households, field scenes, customs and other animal disease detection scenarios. Attached Figure Description

[0073] Figure 1 shows the verification results of Brucella negative samples.

[0074] Figure 2 shows the validation results of negative samples with Brucella primer / probe adjustment.

[0075] Figure 3 shows the verification results of negative samples with Brucella primer / probe adjustment.

[0076] Figure 4 shows the verification results of positive simulated samples from systems 1, 2, and 3.

[0077] Figure 5 shows the verification results of positive simulated samples in systems 4 and 5.

[0078] Figure 6 shows the verification results of positive and negative simulated samples in System 4.

[0079] Figure 7 shows the verification results of positive and negative simulated samples in System 5.

[0080] Figure 8 shows the verification results of negative samples in the optimal reaction system.

[0081] Figure 9 shows the verification results of the BCG detection sensitivity of the optimal reaction system.

[0082] Figure 10 shows the verification results of the BRU detection sensitivity of the optimal reaction system.

[0083] Figure 11 shows the verification results of the competitive reaction between the two bacteria in the optimal reaction system.

[0084] Figure 12 shows the verification results of the competitive reaction between the two bacteria in the optimal reaction system.

[0085] Figure 13 shows the verification results of the negative milk sample extract in the optimal reaction system.

[0086] Figure 14 shows the detection results of mixed samples using the conventional sampling method.

[0087] Figure 15 shows the detection results of mixed samples using the conventional spiking method.

[0088] Figure 16 shows the detection results of the accessibility sampling method.

[0089] Figure 17 shows the detection results of the accessibility sampling method. Detailed Implementation

[0090] To further illustrate the technical means and effects adopted in this application, the following description, in conjunction with embodiments and accompanying drawings, will provide further explanation of this application. It is understood that the specific embodiments described herein are merely illustrative of this application and not intended to limit its scope.

[0091] Where specific techniques or conditions are not specified in the examples, they shall be performed in accordance with the techniques or conditions described in the literature in this field, or in accordance with the product instructions. Reagents or instruments whose manufacturers are not specified are all conventional products that can be purchased from legitimate channels.

[0092] Example 1

[0093] (1) Experimental materials

[0094] Table 1

[0095] The fluorescent basic reaction unit contains dNTPs, polyethylene glycol, dithiothreitol, creatine phosphate, creatine kinase, ATP, Tris, potassium acetate, DNA polymerase, UvsX protein, and UvsY protein.

[0096] The nucleic acid sequences of the upstream primer, downstream primer, and probe for Brucella (hereinafter referred to as BRU) are shown below:

[0097] Upstream primer (SEQ ID NO.1): TCAATGCCATCATGTCGCGCGCTCTGCAGTC;

[0098] Downstream primer (SEQ ID NO.2): TCCTTACGCCCAACGATATCGATCGATTCCG;

[0099] Probe: CTTAATGATGGCAAGCGCAAGGTGCATGA (SEQ ID NO. 3) / iHEXdT / / idSp / / iBHQ1dT / GCGCGTTCTGCCGAC (SEQ ID NO. 4).

[0100] The nucleic acid sequences of the upstream primer, downstream primer, and probe for Mycobacterium bovis (hereinafter referred to as BCG) are shown below:

[0101] Upstream primer (SEQ ID NO.5): CACTAGTGCGCGGACATCGCGTGATCGTT;

[0102] Downstream primer (SEQ ID NO.6): CAGCCAGATGCTGCTCCGTGTCGATTAGATGAGAA;

[0103] Probe: CGATAAGATCAGAACAGGTCATTGCGTCATT(SEQ ID NO.7) / i6FAMdT / / idSp / C / iBHQ1dT / TCGATTGACTATAGCT(SEQ ID NO.8)-Spacer.

[0104] (2) Validation of Brucella negative samples

[0105] Prepare the RAA mixture according to Table 2. Dispense 40 μL of the above RAA mixture into the fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube and add 5 μL of negative water to the reaction tube. Set up 10 parallel experiments with negative water. Place the reaction tube in F6108 for pretreatment and place it in F1620 / F1628 for isothermal amplification at 39℃ for 30 min.

[0106] Table 2

[0107] As shown in Figure 1, no amplification was observed in 10 negative experiments using the Brucella single-pass system, and there were no false positives.

[0108] (3) Brucella primer / probe adjustment and verification

[0109] Prepare the RAA mixture according to Table 3. Dispense 40 μL of the above RAA mixture into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube. Add 5 μL of negative water or negative milk sample extract to the reaction tube. Set up 3 parallel experiments with negative water and 3 parallel experiments with negative milk sample extract. Place the reaction tube in F6108 for pretreatment and place it in F1620 / F1628 for isothermal amplification at 39℃ for 30 min.

[0110] Table 3

[0111] The amount of Brucella primers and probes was adjusted, and the results are shown in Figures 2 and 3. Figure 2 shows the detection results of systems 1, 2 and 3, and Figure 3 shows the detection results of systems 4 and 5. It was found that only the negative milk sample extract of system 3 showed slight amplification in channels 1 and 2, while the negative water and negative milk sample extracts of the other four systems did not show amplification.

[0112] (4) Validation of positive and negative simulated samples of the system after Brucella primer / probe adjustment

[0113] Prepare the RAA mixture according to Table 3. Dispense 40 μL of the above RAA mixture into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube and add 5 μL of sample nucleic acid to the reaction tube. Set up 1 group of negative milk extract, 3 parallel experiments of 50 CFU / mL bovine tuberculosis extract (diluted with negative milk extract), and 3 parallel experiments of 2 copies / μL Brucella plasmid (diluted with negative milk extract). Place the reaction tubes in F6108 for pretreatment and place them in F1620 / F1628 for incubation at 39℃ for 30 min.

[0114] The results are shown in Figures 4 and 5. Figure 4 shows the detection results for Systems 1, 2, and 3, and Figure 5 shows the detection results for Systems 4 and 5. It was found that the negative milk sample (channel 1) in System 3 still showed slight amplification, so this system was not further studied. Systems 1, 2, 4, and 5 (channel 1) all achieved complete detection of 50 CFU / mL Mycobacterium bovis and all 2 copies / μL Brucella plasmids (channel 2) were detected. Based on the principle of saving raw materials, the sensitivity of Systems 4 and 5 will be validated below.

[0115] (5) Validation of positive and negative simulated samples for systems 4 and 5

[0116] Prepare the RAA mixtures for systems 4 and 5 according to Table 3. Dispense 40 μL of the above RAA mixtures into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube and add 5 μL of sample nucleic acid to the reaction tube. Set up 1 group of negative milk extract, 3 parallel experiments of 10 CFU / mL bovine tuberculosis extract (diluted with negative milk extract), and 3 parallel experiments of 1 copy / μL Brucella plasmid (diluted with negative milk extract). Place the reaction tubes in F6108 for pretreatment and place them in F1620 / F1628 for amplification at 39℃ for 30 min.

[0117] Prepare the RAA mixtures for systems 4 and 5 according to Table 3. Dispense 40 μL of the above RAA mixtures into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube and add 5 μL of sample nucleic acid to the reaction tube. Set up one group of negative milk extract, three parallel experiments of 5 CFU / mL bovine tuberculosis extract (diluted with negative milk extract), and three parallel experiments of 0.5 copies / μL Brucella plasmid (diluted with negative milk extract). Place the reaction tubes in F6108 for pretreatment and place them in F1620 / F1628 for amplification at 39℃ for 30 min.

[0118] The results are shown in Figures 6 and 7. Figure 6 shows the detection results of system 4, and Figure 7 shows the detection results of system 5. In systems 4 and 5, channel 1 (Mycobacterium bovis) can detect 10 cfu / mL, and channel 2 (Brucella) can detect 0.5 copies / μL. Finally, system 5 was selected as the amplification system for the integration of Mycobacterium bovis and Brucella into a single tube for detection.

[0119] (6) Verification of 5 negative samples in the system

[0120] Prepare the RAA mixture of system 5 according to Table 3. Dispense 40 μL of the above RAA mixture into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube, and add 5 μL of negative water or sample nucleic acid to the reaction tube. Set up 8 parallel experiments for negative water samples and 8 parallel experiments for negative milk extracts. Place the reaction tubes in F6108 for pretreatment, and then place them in F1620 / F1628 for isothermal amplification at 39℃ for 30 min. Replace the fluorescence basic reaction unit with batch 20240725-1 and repeat the above isothermal amplification process.

[0121] As shown in Figure 8, no amplification was observed in channels 1 and 2. When the fluorescence basic reaction unit (batch 20240725-1) was replaced and a negative verification experiment was performed again, it was found that slight amplification of negative water and negative milk extract was observed in channels 1 and 2. Therefore, the fluorescence basic reaction unit of batch 20231018-2 was still used as the reaction unit for research.

[0122] (7) Sensitivity verification of system 5

[0123] Prepare the RAA mixture of system 5 according to Table 3. Dispense 40 μL of the above RAA mixture into a fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube and add 5 μL of sample nucleic acid to the reaction tube. Set up 4 groups of negative milk extract products, 20 parallel experiments of 10 CFU / mL bovine tuberculosis extract products (diluted with negative milk extract), and 20 parallel experiments of 0.5 copies / μL Brucella plasmid (diluted with negative milk extract). Place the reaction tubes in F6108 for pretreatment and place them in F1620 / F1628 for incubation at 39℃ for 30 min.

[0124] The results are shown in Figures 9 and 10. The detection rate of Mycobacterium bovis at 10 cfu / mL in Channel 1 was 95% (19 / 20), and the detection rate of Brucella at 0.5 copies / μL in Channel 2 was (20 / 20).

[0125] (8) Verification of competitive reaction of system 5

[0126] Prepare the RAA mixture of system 5 according to Table 3. Dispense 40 μL of the above RAA mixture into a fluorescence-based reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube, and add 5 μL of sample nucleic acid to the reaction tube. Place the reaction tube in an F6108 for pretreatment, and then in an F1620 / F1628 incubator at 39℃ for 30 min for amplification. The experimental groups are as follows: four groups of negative milk extract products, with a final concentration of 10 CFU / mL for Bovine Mycobacterium tuberculosis extract products and a final concentration of 10... 4 20 integrated single tubes containing copies / μL of Brucella plasmid (diluted with negative milk extract) to a final concentration of 10. 4 Twenty integrated single tubes containing CFU / mL Mycobacterium bovis extract and Brucella plasmid (diluted with negative milk extract) at a final concentration of 0.5 copies / μL.

[0127] The results are shown in Figures 11 and 12. When the concentrations of Mycobacterium bovis and Brucella were 10 CFU / mL and 10 CFU / mL, respectively... 4 At a concentration of 10 copies / μL, the detection rate of channel one was 100% (20 / 20), and the detection rate of channel two was 100% (20 / 20), indicating no competitive reaction. When the concentrations of Mycobacterium bovis and Brucella were 10... 4 At CFU / mL and 0.5 copies / μL, the detection rate of channel one was 100% (20 / 20), and the detection rate of channel two was 100% (20 / 20), indicating no competitive reaction.

[0128] (9) System 5 negative sample verification

[0129] Prepare the RAA mixture of system 5 according to Table 3. Dispense 40 μL of the above RAA mixture into the fluorescence basic reaction unit. Add 5 μL of magnesium acetate to the cap of the reaction tube. Add 5 μL of negative water or negative milk to the reaction tube to extract the product. Set up 20 parallel experiments. Place the reaction tube in F6108 for pretreatment and place it in F1620 / F1628 for isothermal amplification at 39℃ for 30 min.

[0130] The results are shown in Figure 13. Negative milk sample extracts showed no amplification in channels one and two. In summary, the detection limit for *Mycobacterium bovis* is 10 cfu / mL, and the detection limit for *Brucella* is 0.5 copies / μL. The optimal reaction system for integrating *Mycobacterium bovis* and *Brucella* into a single tube is system 5, which avoids competitive reactions and false positives. After preparation according to System 5, System 5 contains 420 nmol / L BRU upstream primer, 420 nmol / L BRU downstream primer, 120 nmol / L BRU probe, 420 nmol / L BCG upstream primer, 420 nmol / L BCG downstream primer, 120 nmol / L BCG probe, 1.5 mmol / L dNTP, 7.5% w / v polyethylene glycol, 6 mmol / L dithiothreitol, 37.5 mmol / L creatine phosphate, 3.5 μg / U creatine kinase, 7.5 mmol / L ATP, 50 nM Tris, 50 mmol / L potassium acetate, 50 ng / μL DNA polymerase, 60 ng / μL UvsX protein, and 50 ng / μL UvsY protein.

[0131] Example 2

[0132] (1) Experimental materials

[0133] Table 4

[0134] The reaction unit contains 420 nmol / L BRU upstream primer, 420 nmol / L BRU downstream primer, 120 nmol / L BRU probe, 420 nmol / L BCG upstream primer, 420 nmol / L BCG downstream primer, 120 nmol / L BCG probe, 1.5 mmol / L dNTP, 7.5% w / v polyethylene glycol, 6 mmol / L dithiothreitol, 37.5 mmol / L creatine phosphate, 3.5 μg / U creatine kinase, 7.5 mmol / L ATP, 50 nM Tris, 50 mmol / L potassium acetate, 50 ng / μL DNA polymerase, 60 ng / μL UvsX protein, and 50 ng / μL UvsY protein. The primers and probes for BRU and BCG are the same as in Example 1.

[0135] (2) Sample preparation

[0136] a. Dilute the sample with negative milk sample extract to a final concentration of 10 cfu / mL of Mycobacterium bovis and 0.5 copies / μL of Brucella;

[0137] b. Dilute the sample with negative milk sample extract to a final concentration of 10 CFU / mL for Mycobacterium bovis and 10 CFU / mL for Brucella. 4 A mixed sample of copies / μL;

[0138] c. Dilute the sample with negative milk sample extract to a final concentration of Mycobacterium bovis 10⁻⁶. 4 A mixed sample containing cfu / mL and Brucella 0.5 copies / μL;

[0139] d. Dilute the nucleic acid of Mycobacterium bovis with negative milk sample extract to 1 cfu / mL and 0.5 cfu / mL;

[0140] e. Brucella plasmids were diluted with negative milk sample extract to 0.5 copies / μL and 0.1 copies / μL.

[0141] (3) Verification of conventional sampling methods

[0142] Prepare the sample pretreatment system B6108 and the isothermal nucleic acid amplification analyzer F1620 / F1628, and preheat the temperature to 39°C. Add 40 μL of System 5 from Example 1 to a bovine tuberculosis / Bruxelles reaction unit tube, add 5 μL of magnesium acetate to the tube cap, and add 5 μL of negative control or sample nucleic acid. Symmetrically place the reaction unit into the sample pretreatment system B6108, mix, centrifuge, and pre-react for 4 minutes. After pretreatment, sequentially place the units into the isothermal nucleic acid amplification analyzer F1620 / F1628, react at 39°C for 30 minutes, and observe the amplification results in real time via a computer.

[0143] Figure 14 shows the results of 20 tests for sample a, and Figure 15 shows the results of 10 tests for samples b and c. The detection rate of 10 CFU / mL of *Mycobacterium bovis* extract was 100% (20 / 20), and the detection rate of 0.5 copies / µL of *Brucella spp.* plasmid was 100% (20 / 20). In the dual-channel positive sample competition experiment, the final concentration of *Mycobacterium bovis* in channel one was 10 CFU / mL, and the final concentration of *Brucella spp.* plasmid in channel two was 10 CFU / mL. 4 The detection rate was 100% (10 / 10) for both Channel 1 and Channel 2, with no competitive reaction observed. The final concentration of Mycobacterium bovis in Channel 1 was 10. 4The final concentration of Brucella plasmid in channel 2 was 0.5 copies / μL. The detection rate of channel 1 was 100% (10 / 10), and the detection rate of channel 2 was 100% (10 / 10). There was no competitive reaction.

[0144] (4) Verification of accessibility sampling method

[0145] Prepare the sample pretreatment system B6108 and the isothermal nucleic acid amplification analyzer F1620 / F1628, and preheat the temperature to 39°C. Add 25 μL of System 5 from Example 1 to the cap of the bovine tuberculosis / Bruxelles reaction unit tube. Add 25 μL of negative control or sample nucleic acid to the reaction unit tube. Symmetrically place the reaction units into the sample pretreatment system B6108, mix, centrifuge, and pre-react for 4 minutes. After pretreatment, sequentially place them into the isothermal nucleic acid amplification analyzer F1620 / F1628, react at 39°C for 30 minutes, and observe the amplification results in real time via a computer.

[0146] Figure 16 shows the results of 13 detections of Mycobacterium bovis at 1 cfu / mL in sample d and 3 detections of Mycobacterium bovis at 0.5 cfu / mL in sample d. Figure 17 shows the results of 3 detections of Brucella at 0.5 copies / μL in sample e and 13 detections of Brucella at 0.1 copies / μL in sample e. The detection rate of Mycobacterium bovis at 1 cfu / mL was 100% (13 / 13), and the detection rate of Brucella at 0.1 copies / μL was also 100% (13 / 13), indicating improved sensitivity of channels one and two.

[0147] In summary, this application provides an isothermal nucleic acid amplification system for the simultaneous detection of Brucella and Mycobacterium bovis in one tube and its application. The system achieves the simultaneous detection of two pathogens through isothermal nucleic acid amplification, with dual-channel detection without competitive reactions, high specificity, and high sensitivity.

[0148] The applicant declares that the above description is only a specific implementation of this application, but the protection scope of this application is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in this application fall within the protection and disclosure scope of this application.

Claims

1. An isothermal nucleic acid amplification system for simultaneous detection of Brucella and Mycobacterium bovis in one tube, comprising Brucella primer probe, Mycobacterium bovis primer probe, dNTP, polyethylene glycol, dithiothreitol, creatine phosphate, creatine kinase, ATP, Tris, potassium acetate, DNA polymerase, UvsX protein, and UvsY protein.

2. The isothermal nucleic acid amplification system according to claim 1, wherein, The isothermal nucleic acid amplification system includes Brucella primers and probes, Mycobacterium bovis primers and probes, 1–2 mmol / L dNTPs, 5%–10% w / v polyethylene glycol, 2–10 mmol / L dithiothreitol, 25–50 mmol / L creatine phosphate, 2.7–4.3 μg / U creatine kinase, 5–10 mmol / L ATP, 30–100 nM Tris, 25–75 mmol / L potassium acetate, 10–100 ng / μL DNA polymerase, 10–100 ng / μL UvsX protein, and 10–100 ng / μL UvsY protein.

3. The isothermal nucleic acid amplification system according to claim 1 or 2, wherein, The DNA polymerase is derived from Bacillus subtilis and / or Staphylococcus aureus. Preferably, the Brucella primer probe includes a first primer, a second primer, and a first probe; Preferably, the isothermal nucleic acid amplification system comprises a first primer of 200–420 nmol / L, a second primer of 200–420 nmol / L, and a first probe of 100–150 nmol / L; Preferably, the nucleic acid sequence of the first primer includes the sequence shown in SEQ ID NO.1; Preferably, the nucleic acid sequence of the second primer includes the sequence shown in SEQ ID NO.2; Preferably, the nucleic acid sequence of the first probe includes the sequences shown in SEQ ID NO.3 and SEQ ID NO.

4.

4. The isothermal nucleic acid amplification system according to any one of claims 1 to 3, wherein, The Mycobacterium bovis primer probe includes a third primer, a fourth primer, and a second probe; Preferably, the isothermal nucleic acid amplification system includes a 200–420 nmol / L third primer, a 200–420 nmol / L fourth primer, and a 100–150 nmol / L second probe; Preferably, the nucleic acid sequence of the third primer includes the sequence shown in SEQ ID NO.5; Preferably, the nucleic acid sequence of the fourth primer includes the sequence shown in SEQ ID NO. 6; Preferably, the nucleic acid sequence of the second probe includes the sequences shown in SEQ ID NO.7 and SEQ ID NO.

8.

5. An isothermal nucleic acid amplification kit for simultaneous detection of Brucella and Mycobacterium bovis in one tube, comprising the isothermal nucleic acid amplification system as described in any one of claims 1 to 4.

6. The use of the isothermal nucleic acid amplification system according to any one of claims 1 to 4 and / or the isothermal nucleic acid amplification kit according to claim 5 in isothermal amplification of Brucella and / or Mycobacterium bovis.

7. An isothermal nucleic acid amplification method for simultaneous detection of Brucella and Mycobacterium bovis in a tube, comprising: The nucleic acid sample is mixed with the isothermal nucleic acid amplification system according to any one of claims 1 to 4 to obtain a mixed solution, and an isothermal amplification reaction is performed to detect the fluorescence signal in the amplification system and obtain the detection result.

8. The isothermal nucleic acid amplification method according to claim 7, wherein, The volume of the nucleic acid sample is 3–30 μL; Preferably, the volume of the mixture is 45–55 μL; Preferably, the mixture contains magnesium acetate; Preferably, the concentration of magnesium acetate in the mixture is 100–200 mmol; Preferably, the volume of magnesium acetate in the mixture is 3–7 μL.

9. The isothermal nucleic acid amplification method according to claim 7 or 8, wherein, The mixture contains 3–10 μL of nucleic acid sample, 3–7 μL of magnesium acetate at a concentration of 100–200 mmol, and the isothermal nucleic acid amplification system according to any one of claims 1–4, wherein the volume of the mixture is 45–55 μL. Preferably, the mixture contains 10–30 μL of nucleic acid sample and the isothermal nucleic acid amplification system according to any one of claims 1–4, and the volume of the mixture is 45–55 μL.

10. The isothermal nucleic acid amplification method according to any one of claims 7 to 9, wherein, The temperature of the isothermal amplification reaction is 35–45°C; Preferably, the isothermal amplification reaction takes 5 to 40 minutes; Preferably, the isothermal amplification reaction further includes a step of mixing and centrifuging the mixture for 3-5 minutes before the reaction.